Copper Histidinate ( DrugBank: Copper )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 169 | Menkes disease | 1 |
169. Menkes disease
Clinical trials : 6 / Drugs : 6 - (DrugBank : 4) / Drug target genes : 9 - Drug target pathways : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04074512 (ClinicalTrials.gov) | October 15, 2019 | 27/8/2019 | Copper Histidinate Treatment for Menkes Disease | Copper Histidinate Treatment for Menkes Disease | Menkes Disease | Drug: Copper Histidinate | Cyprium Therapeutics, Inc. | NULL | Available | N/A | 6 Years | All | NULL |